J. Goldman & CO LP Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 14, 2019	SELL	$34.52 - $53.29 $1.8 Million - $2.77 Million	-52,000 Reduced 50.0%	52,000 $2.68 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $1.16 Million - $1.67 Million	39,000 Added 60.0%	104,000 $3.85 Million
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $1.77 Million - $2.32 Million	-54,000 Reduced 45.38%	65,000 $2.44 Million
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $1.06 Million - $1.89 Million	44,700 Added 60.16%	119,000 $4.7 Million
Q4 2017 Feb 16, 2018	BUY	$20.44 - $35.56 $1.52 Million - $2.64 Million	74,300	74,300 $2.01 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.